April 2013 Newsletter

Posted By on April 22, 2013

“Simple morality dictates that unless and until someone can prove the unborn human is not alive, we must give it the benefit of the doubt and assume it is (alive). And, thus, it should be entitled to life, liberty and the pursuit of happiness.” – Ronald Reagan 1982

Please pray for a culture of life in America.  Pray that one by one, family by family, women and men will say No to abortion.


Time to Speak in the Church

The Gospel of Jesus Christ is the most positive, powerful, life-affirming, and life-changing message in the universe. The Gospel speaks directly to these issues of life and death. The Gospel, in the board sense, speaks of what God does that gives value to human life. It may seem backward, but when it comes to speaking up for the sanctity of human life in the Church and convincing others to do the same, we need to start with the Gospel, not the prohibitions of the law. Only when we understand the value that God gives to life will be able to realize fully the weight of the law against harming human life.

Abortionist at Center of Maryland Death Investigation Licensed to Do Abortions in Indiana

Lifeline Report March 2013

On February 7, Jennifer McKenna Morbelli of New York allegedly died of abortion complications after ungoing a late-term abortion performed by LeRoy Carhart at his Germantown, Maryland facility. Her daughter, Madison Leigh, was 33 weeks along. Carhart’s abortion ties to Indiana span more than two decades.

Third -trimester abortions are a multi-day process. On the first day, the abortionist injects a lethal drug into the baby’s heart, causing death. On the remaining days, the mother prepares for labor to remove her now deceased baby. Only four abortionists perform late-term abortions in the United States. Regularly, out-of-town mothers spend nights at a hotel and return to the facility during the day. In this case witnesses saw Morbelli grow paler and weaker each day she returned to Carhart’s facility.

Carhart is well-known for his willingless to perform late-term abortions. At the recent Sundance Film Festival, Carhart was featured as a “hero” in an abortion documentary. Carhart has also publically indicated his desire to advance his abortion business; in 2010, he said he would open facilities in Indianapolis and other cities around the country.

In 1992, Planned Parenthood of Indiana hired Carhart to perform abortions at its Bloomington location after searching for an abortionist for two years. After spending many years primarily doing abortions in Nebraska, Carhart returned to Indiana after his 2010 statement about advancing his abortion business. Carhart peforms first trimester abortions at Affiliated Women’s Services in Indianapolis. Carhart’s Indiana license expires June 30, 2013.

“Indiana Right To Life is concerned about Carhart performing abortions in Indiana,” said Mike Fichter, President and CEO of Indiana Right To Life. “Reports about Morbelli’s death indicate that Carhart was unreachable when Morbelli started to experience chest pains and other effects from her abortion. This alleged disregard for a patient’s health and safety is alarming. We believe this woman’s death justifies the State of Indiana revoking Carhart’s abortion license until a full investigation is complete.”

The Maryland Office of the Chief Medical Examiner and the Montgomery County Police Department are investigating Morbell’s death.

“We understand Morbelli desired an abortion for her daughter because of recently discovered fetal abnormalities,” continued Fichter. “We want all pregnant mothers who receive the same news to know that a better outcome for both mother and child exists by bringing the baby to term with support of perinatal hospice and palliative care. We will continue to highlight these resources in Indiana.”

Chemical Abortion Bill Passes House Public Policy Committee

INDIANAPOLIS – Today, Senate Bill (SB) 371 passed the Indiana House Public Policy Committee by a vote of 8-5. SB 371 introduces health and safety standards into the chemical abortion industry that currently lacks state oversight.

SB 371 requires that chemical abortion facilities meet the same licensing requirements that other abortion facilities are subject to. The requirements deal with reporting standards, physician oversight, cleanliness standards and building accessibility.

When chemical abortion drugs are used up to nine weeks of pregnancy, past the Food and Drug Administration’s seven-week guideline, complication rates drastically rise. According to the New England Journal of Medicine, the failure rate of the chemical abortion drug is 8 percent at 7 weeks, but the failure rises to 23 percent at 9 weeks. When the abortion is incomplete, facilities needs to be prepared to deal with a woman experiencing uncontrollable bleeding, infection or other potential side effects of the abortion drug. The licensing requirements in SB 371 will establish that chemical abortion facilities maintain an environment appropriate for dealing with these conditions.

During the committee hearing, SB 371 was amended to include informed consent provisions, change the date by which facilities must have licensing, remove ultrasound requirements and prohibit the Indiana State Department of Health from grandfathering facilities that were not given grandfathered status in previous laws.

“We applaud the House Public Policy Committee for prioritizing women’s health in Indiana,” said Mike Fichter, President and CEO of Indiana Right to Life. “While not all the amendments that passed were supported by Indiana Right to Life, we’re pleased that SB 371 brings crucial oversight to the chemical abortion industry. SB 371 strengthens current abortion law in Indiana by not allowing any abortion facility to operate without oversight.”

SB 371, was authored by Sen. Travis Holdman (District 19) in the Senate and it passed on Feb. 26, by a vote of 33 to 16. Reps. Sharon Negele (District 13), Bob Morris (District 84) and Matthew Lehman (District 79) are sponsors of SB 371 in the Indiana House. With today’s committee passage, SB 371 can now advance to a vote in the Indiana House.

Comments are closed.